RDGL · Vivos Inc
$0.06
+0.00 (+2.06%)
At close · Jul 30
Going-concern doubt
— flagged May 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Based on the Company's financial history since inception, the Company's independent registered public accounting firm has expressed substantial doubt as to the Company's ability to continue as a going concern.”View the 10-Q filed May 14, 2026
Market Cap
$29.33M
Shares
493.89M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.06
Open$0.06
Day$0.06–0.06
52W$0.04–0.14
Avg vol 30d2.1M
Short int67K · 0.0% float · 1.0d
Short vol54%
DataJan 2020–Jul 2026
Filing10-Q · May 14
Up next
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 14, 2026
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Sell
Momentum
Weak
Sentiment
Bullish
Fundamentals
Fair
Quant / Vol
Very High
Market backdrop
VIX 17.1 · elevated
Equity put/call 0.61
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−18%
below
Price vs 50-day avg
−7%
below
RSI (14)
47
neutral
MACD trend
Negative
52-week position
17%
mid-range
Volume (OBV)
Confirms
volume backs price
Momentum
relative strength
1-month return
+2%
trailing
6-month return
−13%
trailing
YTD return
−14%
this year
Relative strength
−22%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
0% holders QoQ
Insider flow
Accumulating
Net +$30.1K over 90 days · 0% sells
Short interest
Falling
0.01% of float · ▼ -52.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
1 holders — 13F breadth
Squeeze score
17
low risk · 0–100
Fundamentals
Revenue growth
+23%
Y/Y
Gross margin
-1196%
contracting
EPS growth
0%
Y/Y
Free cash flow
$-2.2M
Balance sheet
$2.2M
net cash
Quant / Vol
risk profile
Volatility
99%
annualized · 1-yr
Max drawdown
−61%
past year
ATR
13.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−18%
Bearish
Price vs 50-day avg
−7%
Bearish
RSI (14)
47
Neutral
MACD trend
Negative
Bearish
52-week position
17%
Neutral
Volume (OBV)
Confirms
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $0 › 200d $0 — 200d above 50d
Institutional flow
Flat
0% holders QoQ
Insider flow
Accumulating
Net +$30.1K over 90 days · 0% sells
Short interest
Falling
0.01% of float · ▼ -52.9% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
1 holders — 13F breadth
Price context
position in its 52-week range
52-wk low $0
Now $0 · 17%
52-wk high $0
vs 200-day avg -18%
vs 50-day avg -7%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
RDGL
this stock
Vivos Inc
|
$29.33M | -13.8% | +144.3% | — | 0.0% |
|
ABT
Abbott Laboratories
|
$183.95B | -15.3% | +5.7% | 29.6 | 1.4% |
|
SYK
Stryker Corp
|
$133.42B | -0.7% | +11.2% | 36.1 | 1.8% |
|
MDT
Medtronic plc
|
$109.71B | -10.0% | +8.4% | 23.0 | 1.5% |
|
BSX
Boston Scientific Corp
|
$67.55B | -51.8% | +5.5% | 19.0 | 1.9% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Institutional Holders
Holders
1
- % held
- 0.0%
- Net QoQ
- 0 sh
- Top holder
- CAPTRUST FINANCIAL ADVISO…
Held
Float
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| RDGL | +1.2% | +2.2% | -12.5% | -2.9% | -13.8% |
| SPY | +0.5% | -0.6% | +9.5% | -0.7% | +8.8% |
| vs SPY | +0.7% | +2.8% | -22.0% | -2.3% | -22.6% |